Corporation
Lifestyle
250-Yen Americano Proves a Hit… Baekdabang Sells 1,000 Cups a Day in Tokyo
Baek Jong-won, CEO of #The BORN Korea, is making inroads into the morning commutes of office workers in Tokyo, Japan, with his coffee brand, Baekdabang. Instead of bustling commercial districts, the b…
Lifestyle
NEXTBIOMEDICAL CO., LTD. and NexSphere F Race to Enter the U.S. Market... Will Sales See a Quantum Leap Soon?
Innovative biomedicine company #NEXTBIOMEDICAL CO., LTD. is accelerating its entry into the U.S. market with “Nexsphere-F™,” a rapidly degradable embolization therapy for arthritis pain that it develo…
Lifestyle
"Just Enjoy the Barre Class for Now"... Viewori Targets the Wellness Crowd [Report]
On the afternoon of the 18th, at the Vuori pop-up store in Seongsu-dong, Seongdong-gu, Seoul, a different scene unfolded as I passed through the first and second floors—where clothes were displayed—an…
Lifestyle
Remedi Surges 23%; Bio Solution Climbs on China Expansion [K-bio pulse]
Portable X-ray manufacturer Remedi saw its stock price surge after reporting explosive earnings growth. The company is expanding rapidly not only in South Korea but also overseas, raising expectations…
Lifestyle
Remedy Soars 23% on Strong Earnings… Bio Solution Co.,Ltd., Expanding into China, Also Draws Attention [Bio Spotlight]
The stock price of #Remedy, a portable X-ray company, rose sharply as the company posted explosive earnings growth. As Remedy continues to grow rapidly both domestically and internationally, it is exp…
Lifestyle
NEXTBIOMEDICAL CO., LTD., Which Made Its Mark Globally with NexPowder, Named a “KOSDAQ Rising Star” for the Second Consecutive Year
#NEXTBIOMEDICAL CO., LTD., a company specializing in innovative medical devices, has been named to the Korea Exchange’s “KOSDAQ Rising Star” list for the second consecutive year, once again demonstrat…
Lifestyle
Celltrion, Buoyed by Direct Sales, Expands into Asia’s Pharm-Emerging Markets... Solidifies No. 1 Position and Prepares New Drugs
Celltrion(068270)Celltrion is strengthening its market dominance in Asia—a leading “Shinhung” (emerging pharmaceutical) market—by leveraging its unrivaled direct-to-market competitiveness. While its f…
Lifestyle
Moving Away from OEM Production to In-House Manufacturing… Dongwon F&F Targets the Frozen Chicken Market with ‘Kebasak’
Dongwon F&F is ramping up its efforts in the frozen chicken business in earnest. While it previously sold products such as “Whole-Meat Chicken” and “Cuisine Inside” as non-core items, the company is n…
Lifestyle
SEERS Sold for 1,000 Won, Net Profit of 440 Won... Pharmaceuticals, Biotech, and Healthcare Rank 'Top in Profitability'
#SEERS Technology is rapidly emerging as the most profitable company among domestic pharmaceutical, biotech, and healthcare firms. In the first half of this year, the company generated 26.8 billion wo…
Lifestyle
Park Dong-hyun, CEO of Mezion Pharma Co., Ltd.: “A 20-Year Battle for Udenafil… Moving Beyond Fontan to ADPKD”
“While developing Udenafil over the past 20 years, we reviewed countless other new drug candidates. But in the end, we couldn’t find a compound as promising as this one.”Park Dong-hyun, CEO (Chairman)…